Bruker 8-K
Leadership change
Board adds immunologist Eicke Latz as life-science work expands; declares $0.05/share quarterly dividend.
Filed 2026-11-16 07:00 ET
- 5.02 Officer/director change
- 8.01 Other Events
- 9.01 Financial Statements and Exhibits
Summary
Board expansion and quarterly dividend declaration. Bruker added one seat to expand its Board to 12 and appointed Eicke Latz, an immunology scientist and co-founder of five biotechnology companies, effective 1/1/2027; he will serve through the 2029 Annual Meeting and receive compensation consistent with other non-employee directors. The appointment brings scientific and biopharma experience as Bruker expands its work in life-science tools, disease biology research, molecular diagnostics and drug discovery.
The Board declared a $0.05-per-share dividend on 11/12/2026, payable 1/7/2027 to shareholders of record on 12/21/2026.
Get emails when companies you follow file: email digest settings.
The summary is written by an AI model reading the filing.
Model 005 · prompt v192 · 2026-11-16 15:36:46Z